SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-05-047954
Filing Date
2005-03-11
Accepted
2005-03-11 16:39:01
Documents
11
Period of Report
2005-03-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 62810
2 AMENDED AND RESTATED BYLAWS, AMENDED AS OF MARCH 7,2005 dex31.htm EX-3.1 130433
3 FORM OF THE AMENDED SECTION 16 OF THE AMENDED AND RESTATED BYLAWS dex32.htm EX-3.2 1500
4 AMENDED AND RESTATED 1991 EQUITY INCENTIVE PLAN dex101.htm EX-10.1 74920
5 AMENDED AND RESTATED 1997 EQUITY INCENTIVE PLAN dex102.htm EX-10.2 137825
6 AMENDED AND RESTATED 1999 EQUITY INCENTIVE PLAN dex103.htm EX-10.3 131731
7 AMENDED AND RESTATED AMGEN INC. PERFORMANCE AWARD PROGRAM dex104.htm EX-10.4 40305
8 FORMS OF STOCK OPTION GRANT AGREEMENTS AND RESTRICTED STOCK UNIT AGREEMENTS dex105.htm EX-10.5 76470
9 FORMS OF STOCK OPTION GRANT AGREEMENTS AND RESTRICTED STOCK UNIT AGREEMENTS dex106.htm EX-10.6 75972
10 FORMS OF STOCK OPTION GRANT AGREEMENTS FOR THE 1999 EQUITY INCENTIVE PLAN dex107.htm EX-10.7 50238
11 FORM OF PERFORMANCE UNIT AGREEMENT dex108.htm EX-10.8 19073
  Complete submission text file 0001193125-05-047954.txt   804673
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12477 | Film No.: 05675962
SIC: 2836 Biological Products, (No Diagnostic Substances)